MAOLAC

Precision Proteins

Health Tech & Life Sciences
Private

Company Overview

Snapshot

Founded in January 2018 by Maya Ashkenazi (Otmazgin), MAOLAC operates with 11–50 employees. The company has raised $4.05M across 4 funding rounds from 9 investors. In May 2024, MAOLAC won the NutraIngredients Start-up Award.

Business overview

MAOLAC develops novel, high-impact Bio Functional Proteins (BFPs) for integration into food, beverages, supplements, and cosmetic products. The company's functional ingredients are based on its proprietary Proteomics Discovery Platform (MAOreka), which uses AI tools, including NLP search algorithms and web scraping technologies, to enrich specific groups of functional proteins. MAOLAC examines various protein sources, both dairy and plant-based, to identify protein combinations with high bio-similarity to human breast milk, targeting effects such as anti-inflammation and gut health. The company serves the health tech and life sciences sector, focusing on nutrition and food ingredients.

Strategic signal

In May 2024, MAOLAC won the NutraIngredients Start-up Award, signaling significant industry recognition for its innovative approach to bio-functional proteins. This award validates the company's scientific advancements and market potential, particularly in leveraging AI to develop ingredients with high bio-similarity to human breast milk for health and nutrition applications.

Company Intelligence Q&A

What is MAOLAC's core technology?
MAOLAC's core technology is its proprietary Proteomics Discovery Platform (MAOreka), which utilizes AI tools, including NLP search algorithms and web scraping, to identify and enrich specific groups of functional proteins from dairy or plant-based sources that have high bio-similarity to human breast milk.
When was MAOLAC founded and by whom?
MAOLAC was founded in January 2018 by Maya Ashkenazi (Otmazgin).
What was a significant recent achievement for MAOLAC?
In May 2024, MAOLAC won the NutraIngredients Start-up Award, recognizing its innovative work in developing bio-functional proteins.
Has MAOLAC received any grants?
In September 2024, MAOLAC received a grant from the Israel Innovation Authority.
Which investors participated in MAOLAC's May 2022 funding round?
In May 2022, MAOLAC received funding from investors including OurCrowd and theFoodTechLab.

External links